Commentary: Pneumococcal immunization may not be cost-effective in the elderly in developed countries.
Waugh
Norman
N
Department of Public Health, University of Aberdeen, Medical School Buildings, Foresterhill, Aberdeen AB25 2ZD, Scotland, UK. n.r.waugh@abdn.ac.uk
D000368:Aged; D003362:Cost-Benefit Analysis / Q000379:methods; D017048:Health Care Costs; D006801:Humans; D011008:Pneumococcal Infections / Q000191:economics / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000191:economics* / Q000627:therapeutic use; D011014:Pneumonia / Q000191:economics / Q000517:prevention & control; D006113:United Kingdom
D022242:Pneumococcal Vaccines